OpenVSafe by OpenVAERS
Search V-safe

7KU-24047-78751

2 vaccinations 7 coded responses 17 check-ins 7 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
981 / WA
Registered
2021-04-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-16
    Registered in v-safe
  2. 2021-04-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-16
    Survey response — day 0, dose 1
    MedDRA: Familial periodic paralysis, Injection site coldness, Injection site paraesthesia, Paraesthesia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Injection arm paresthesias (cold, tingling); unusual frequency/severity of hypokalemic periodic paralysis episodes, requiring more K than usual to abort
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hypokalaemia, Paralysis, Unevaluable event — Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea
    Free text: Potassium dose to prevent symptoms increased by about 2x (hypokalemic periodic paralysis)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cough, Dyspnoea — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Dyspnea, cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  9. 2021-04-23
    Health check-in — day 7, dose 1
    Feeling: Good · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  10. 2021-04-30
    Survey response — day 14, dose 1
    MedDRA: Arthralgia, Cardioversion, Dehydration — Feeling: Good
    Free text: Constant mild joint pain. More easily dehydrated.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-07
    Dose 2 — Pfizer-BioNTech
  12. 2021-05-07
    Survey response — day 0, dose 2
    MedDRA: Condition aggravated, Familial periodic paralysis, Pre-existing disease, Vaccine positive rechallenge — Feeling: Good · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Increased severity of hypokalemic periodic paralysis symptoms (attacks trigger more easily, need more potassium to abort attack, etc.) Same as with first shot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-05-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Worsened control of hypokalemic periodic paralysis symptoms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-05-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood potassium abnormal, Blood potassium decreased, Blood potassium increased — Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Free text: Finicky potassium levels
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-05-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  19. 2021-05-14
    Health check-in — day 7, dose 2
    Feeling: Good · Joint pains, Fatigue or tiredness
    Adult check-in
  20. 2021-05-21
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-16Pfizer-BioNTech
22021-05-07Pfizer-BioNTech

Free text

Release 7 — day 0, dose 1

2021-04-16

Systemic reaction (other): Injection arm paresthesias (cold, tingling); unusual frequency/severity of hypokalemic periodic paralysis episodes, requiring more K than usual to abort

Release 7 — days 1–6 daily, dose 1

2021-04-17

Systemic reaction (other): Potassium dose to prevent symptoms increased by about 2x (hypokalemic periodic paralysis)

2021-04-21

Systemic reaction (other): Dyspnea, cough

Release 8 — day 14, dose 1

2021-04-30

Symptoms: Constant mild joint pain. More easily dehydrated.

Release 8 — day 0, dose 2

2021-05-07

Systemic reaction (other): Increased severity of hypokalemic periodic paralysis symptoms (attacks trigger more easily, need more potassium to abort attack, etc.) Same as with first shot.

Release 8 — days 1–6 daily, dose 2

2021-05-09

Systemic reaction (other): Worsened control of hypokalemic periodic paralysis symptoms.

2021-05-11

Systemic reaction (other): Finicky potassium levels

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDCardioversion ○ ✓ ○
SDDehydration ✓ · ✓
SROBlood potassium abnormal ✓ · ✓
SROBlood potassium decreased ○ ✓ ○
SROBlood potassium increased ○ ✓ ○
SROCondition aggravated ✓ ✓ ✓
SROCough ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROFamilial periodic paralysis ✓ ✓ ✓
SROHypokalaemia · · ✓
SROInjection site coldness ○ ✓ ○
SROInjection site paraesthesia ○ ✓ ○
SROParaesthesia ✓ · ✓
SROParalysis · · ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ○
SROVaccine positive rechallenge ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release